Prediction of Outcomes With a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated With Radiation Therapy and Temozolomide

Precision medicine has been most successful in targeting single mutations, but personalized medicine using broader genomic tumor profiles for individual patients is less well-developed. We evaluate a genomics-informed computational biology model (CBM) to predict outcomes from standard treatments and to suggest novel therapy recommendations in glioblastoma (GBM).

International Journal of Radiation Oncology, Biology, Physics 2020 Glioblastoma Multiforme